Structure Therapeutics Stock Forecast - Accumulation Distribution
GPCR Stock | 33.15 0.60 1.78% |
Structure Stock Forecast is based on your current time horizon. Although Structure Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Structure Therapeutics' systematic risk associated with finding meaningful patterns of Structure Therapeutics fundamentals over time.
Structure |
Previous Accumulation Distribution | Accumulation Distribution | Trend |
27190.98 | 47601.42 |
Check Structure Therapeutics Volatility | Backtest Structure Therapeutics | Trend Details |
Structure Therapeutics Trading Date Momentum
On October 03 2024 Structure Therapeutics American was traded for 42.29 at the closing time. The top price for the day was 43.29 and the lowest listed price was 41.33 . The trading volume for the day was 249.1 K. The trading history from October 3, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.76% . The trading price change against the current closing price is 0.07% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Structure Therapeutics to competition |
Other Forecasting Options for Structure Therapeutics
For every potential investor in Structure, whether a beginner or expert, Structure Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Structure Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Structure. Basic forecasting techniques help filter out the noise by identifying Structure Therapeutics' price trends.Structure Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Structure Therapeutics stock to make a market-neutral strategy. Peer analysis of Structure Therapeutics could also be used in its relative valuation, which is a method of valuing Structure Therapeutics by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Structure Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Structure Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Structure Therapeutics' current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Structure Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Structure Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Structure Therapeutics shares will generate the highest return on investment. By undertsting and applying Structure Therapeutics stock market strength indicators, traders can identify Structure Therapeutics American entry and exit signals to maximize returns.
Structure Therapeutics Risk Indicators
The analysis of Structure Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Structure Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting structure stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 2.88 | |||
Standard Deviation | 4.16 | |||
Variance | 17.27 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Structure Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Structure Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Structure Stock
0.67 | VTRS | Viatris | PairCorr |
0.64 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
0.51 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
0.31 | EBS | Emergent Biosolutions | PairCorr |
0.31 | GILD | Gilead Sciences | PairCorr |
The ability to find closely correlated positions to Structure Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Structure Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Structure Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Structure Therapeutics American to buy it.
The correlation of Structure Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Structure Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Structure Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Structure Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Structure Stock Analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.